Vivos acquired SCN, which is expected to boost future growth and increase sleep testing revenue.
2 reports, 1 independent
Updated Aug 15
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vivos acquired SCN, which is expected to boost future growth and increase sleep testing revenue.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GuruFocus.comVivos Therapeutics Inc (VVOS) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... This article first appeared on GuruFocus. Revenue: Decreased by 6% to $3.8 million in Q2 2025 compare